M Schultzberg
Overview
Explore the profile of M Schultzberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
2131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foster G, Schultzberg M, Dahl D, Goldstein M, Verhofstad A
Int J Dev Neurosci
. 2014 May;
3(6):597-608.
PMID: 24875105
The distribution of three catecholamine synthetic enzymes (tyrosine hydroxylase, l-aromatic acid decarboxylase and dopamine β-hydroxylase), of the catecholamines themselves (dopamine and noradrenaline) and of a marker for neuronal intermediate filaments...
2.
Foster G, Schultzberg M
Int J Dev Neurosci
. 2014 May;
2(4):387-407.
PMID: 24874149
The development of neuropeptide Y-like immunoreactive structures in the foetal rat brain was investigated by means of the indirect immunohistofluorescence technique. Neuropeptide Y-like immunoreactive cells and fibres first appeared on...
3.
Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxen Irving G, Eriksdotter M, et al.
J Intern Med
. 2014 Jan;
275(4):428-36.
PMID: 24410954
Objective: Little is known about the transfer of essential fatty acids (FAs) across the human blood-brain barrier (BBB) in adulthood. In this study, we investigated whether oral supplementation with omega-3...
4.
Husberg B, Schultzberg M
Pediatr Surg Int
. 2013 Sep;
11(1):33-40.
PMID: 24057468
The pathophysiology of the impaired sphincter function in Hirschsprung's disease is still unclear. The peptidergic innervation of the aganglionic large intestine is known to be disturbed. The present study analyzes...
5.
Foster G, Schultzberg M, Goldstein M
Neurochem Int
. 2010 May;
6(6):761-71.
PMID: 20488105
The development of tyrosine hydroxylase- and neuropeptide Y-immunoreactive cell bodies in the foetal rat brain was analyzed immunohistochemically using antibodies raised against tyrosine hydroxylase and neuropeptide Y. Possible co-existence of...
6.
Spulber S, Bartfai T, Schultzberg M
Brain Behav Immun
. 2009 Mar;
23(5):573-9.
PMID: 19258032
The interleukin-1 (IL-1) family is unique in its including an endogenous antagonist of the IL-1 receptor (IL-1ra). IL-1ra has been shown to antagonise IL-1 signalling so effectively, that it came...
7.
Oprica M, Hjorth E, Spulber S, Popescu B, Ankarcrona M, Winblad B, et al.
J Cell Mol Med
. 2007 Sep;
11(4):810-25.
PMID: 17760842
Inflammation is associated with both acute and chronic neurological disorders, including stroke and Alzheimer's disease (AD). Cytokines such as interleukin (IL)-1 have several activities in the brain both under physiological...
8.
Rahman S, van Dam A, Schultzberg M, Crisby M
J Neuroimmunol
. 2005 Oct;
169(1-2):59-67.
PMID: 16198427
Inflammation in the central nervous system is an early hallmark of many neurodegenerative diseases including Alzheimer's disease (AD). Recently, increasing evidence suggests that hypercholesterolemia during midlife and abnormalities in the...
9.
Crisby M, Rahman S, Sylven C, Winblad B, Schultzberg M
Neurosci Lett
. 2004 Sep;
369(2):87-92.
PMID: 15450674
Hypercholesterolemia has been suggested as a risk factor for Alzheimer's disease (AD). A genetic risk factor for AD is the E4 allele of apolipoprotein E (apoE). ApoE is the major...
10.
Oprica M, Eriksson C, Schultzberg M
J Cell Mol Med
. 2003 Aug;
7(2):127-40.
PMID: 12927051
The evidence of inflammatory processes in the clinical manifestations and neuropathological sequelae of epilepsy have accumulated in the last decade. Administration of kainic acid, an analogue of the excitatory amino...